Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 530317 | NSE Symbol : | ISIN : INE362C01012 | Industry : Pharmaceuticals - Indian - Bulk Drugs |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
06-Feb-2025	12-Feb-2025	Quarterly Results	GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve the un-audited standalone and consolidated financial results for the quarter and nine months ended December 31 2024 amongst other routine matters. Unaudited Financial Results For the Quarter and Nine Months Ended December 31, 2024 (As Per BSE Announcement Dated on: 12/02/2025)
08-Nov-2024	14-Nov-2024	Quarterly Results	GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve and take on record the un-audited financial results for the quarter and half year ended September 30 2024 amongst other routine matters. Submission of unaudited financial results of the Company and Limited review report for Quarter and Half Year Ended September 30, 2024 (As per BSE Announcement Dated on 14/11/2024)
09-Aug-2024	14-Aug-2024	Quarterly Results	GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve the un-audited Financial Results/Statements for the quarter ended June 30 2024 and other business items Un-Audited Financial Results for the Quarter Ended on 30.06.2024 (As Per BSE Announcement dated on 14.08.2024)
24-May-2024	30-May-2024	Quarterly Results	GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve audited financial results/statements for the quarter and year ended on 31st March 2024 Outcome of the Board Meeting of Godavari Drugs Limited (the Company) held on Thursday 30th May, 2024 Financial results for the Quarter and year ended on 31st March 2024 (As Per BSE Announcement Dated on 30.05.2024)
06-Feb-2024	13-Feb-2024	Quarterly Results	GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday February 14th 2023 inter alia to approve and take on record the un-audited financial results for the quarter ended December 31 2023 amongst other routine matters. The trading window for dealing in securities of the Company for all insiders as defined under the Code of Conduct for Prevention of Insider Trading (the Code) of the Company has been closed from Saturday December 30 2023 to Friday February 16 2024 (both days inclusive) in compliance with the provisions of the Code of the Company read with SEBI (Prohibition of Insider Trading) Regulations 2015. Accordingly the trading window will be opened from Saturday February 17 2024. This is for your information and records. The Board Meeting to be held on 14/02/2024 has been revised to 13/02/2024 The Board Meeting to be held on 14/02/2024 has been revised to 13/02/2024 (As Per BSE Announcement dated on 07.02.2024) Outcome of the Board Meeting of Godavari Drugs Limited (the Company) held on Tuesday 13th February, 2024 Un-Audited Financial Results and Limited Review Report for the Quarter ended 31st December, 2023 (As Per BSE Announcement Dated on 13/02/2024)
07-Nov-2023	14-Nov-2023	Quarterly Results	GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve un-audited financial results for the quarter and half year ended September 30 2023 amongst other routine matters. Outcome of the Board Meeting of Godavari Drugs Limited (the ''Company'') held on Tuesday, November 14, 2023 (As Per BSE Announcement Dated on 14.11.2023)
03-Aug-2023	11-Aug-2023	Quarterly Results	GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve GODAVARI DRUGS LTD. has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023inter alia to consider and approve results for the quarter ended 30.06.2023Outcome of the Board Meeting of Godavari Drugs(the Company) held on Friday 11th August, 2023 Outcome of the Board Meeting of Godavari Drugs(the Company) held on Friday 11th August, 2023 (As Per BSE Announcement Dated on 11.08.2023)
22-May-2023	29-May-2023	Accounts	GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve the Audited financial results of the Company for the fourth Quarter and Year ended 31st March 2023. The Board Meeting to be held on 29/05/2023 has been revised to 29/05/2023 The Board Meeting scheduled to be held on Monday, 29th May, 2023 at 2:30 PM, this is to inform you that the said meeting is rescheduled at 11:30 AM instead of 2:30 PM (As Per BSE Announcement Dated on 27.05.2023) With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its meeting held on Monday, 29th May, 2023 through Vedio conferencing, interalia, considered and approved the audited Financial Results for the quarter and year ended 31st March, 2023 and statement of Assets and Liabilities along with Cash Flow statements. Copy of Audited Financial Results for the for the quarter and year ended 31st March, 2023, along with Statement of Assets and Liabilities, cash Flow Statements and Audit Report is enclosed herewith. The meeting commenced at 11.15 A.M. and concluded at 01.20 P.M. Considered the appointment of Mr. Venkatesh Achanta as Company Secretary. The Disclosure pertaining to the appointment is annexed along with his profile. Outcome of Board Meeting (As Per BSE Announcement dated on 29.05.2023)
03-Feb-2023	14-Feb-2023	Quarterly Results	GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve the unaudited financial results of the Company for the Quarter ended 31st December 2022. Outcome of the Board Meeting held on 14.02.2023 for approval of Unaudited Financial Results for the quarter ended December, 2022 (As per BSE Announcement Dated on 14/02/2023)
06-Nov-2022	12-Nov-2022	Quarterly Results	GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 inter alia to consider and approve 1. To Consider and approve the Unaudited Standalone Financial Results of the Company for the Quarter and half Year ended 30th September 2022; 2. To Consider draft notice of Postal Ballot and Appointment of Scrutinizer for E-voting Outcome of Board Meeting held on 12th November,2022 for approval of unaudited Financial Statements for the quarter ended September, 2022 (As Per BSE Announcement Dated 12.11.2022)
04-Aug-2022	13-Aug-2022	Quarterly Results	GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2022 inter alia to consider and approve unaudited financials for the quarter ended 30.06.2022 Outcome of the Board Meeting held on 13.08.2022 at 11:30 A.M. through Video Conferencing through Zoom Application Unaudited Financial Results for the quarter ended 30.06.2022 (As Per BSE Announcement Dated on 13/08/2022)
13-Apr-2022	19-Apr-2022	Quarterly Results	GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/04/2022 inter alia to consider and approve 1. Audited Standalone Financial Results of the Company for the Fourth Quarter and Financial Year ended 31st March 2022. 2. To discuss and approve Draft Boards Report and Draft Management Discussion and Analysis Report for the Financial Year ended 31st March 2022 3. To Approve the notice calling 34th Annual General Meeting. Outcome of the Board Meeting held on 19.04.2022 commenced at 11:30 A.M. and concluded at 1:10 P.M. Approval of Financial Results for quarter and year ended 31.03.2022 (As Per BSE Announcement dated on 19.04.2022) Approval of Financial Results for quarter and year ended 31.03.2022 (As Per BSE Announcement Dated on 10.05.2022)
07-Feb-2022	14-Feb-2022	Quarterly Results	GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve Unaudited Financial Statements for quarter ended December 2021 Outcome of the Board Meeting held on 14.02.2022 for approval of Unaudited Financial Statements for the quarter ended 31.12.2021. (As Per BSE Announcement Dated 14.02.2022)
03-Nov-2021	12-Nov-2021	Quarterly Results	Quarterly Results Outcome of the Board Meeting held on 12.11.2021 for approval of unaudited financials for the quarter ended 30.09.2021 (As per BSE Announcement Dated on 12/11/2021)
06-Aug-2021	14-Aug-2021	Quarterly Results	GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2021 inter alia to consider and approve Unaudited Financial Statements for the quarter ended 30.06.2021. Outcome of Board Meeting held on 14.08.2021 for approval of Unaudited Financial Statement Unaudited Financial Results for the quarter ended 30.06.2021 (As Per BSE Announcement Dated 14.08.2021)

1 2

LOGIN HERE

Godavari Drugs Ltd

Board Meeting